Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su-Pin Choo

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
American Journal of Clinical Oncology|March 8, 2011
Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinomaSoo-Fan Ang, Sze-Huey Tan, Han-Chong Toh, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2012
Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancerMohamad Farid, Balram Chowbay, Xiangai Chen, et al.
Asia-Pacific Journal of Clinical Oncology|April 18, 2020
Recommendations to improve the clinical adoption of NGS-based cancer diagnostics in SingaporeDavid Shao-Peng Tan, Daniel Shao-Weng Tan, Iain Bee Huat Tan, et al.
Asia-Pacific Journal of Clinical Oncology|December 1, 2010
Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathyWen-Yee Chay, Sze-Huey Tan, Yew-Long Lo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysisChee-Kian Tham, Su-Pin Choo, Wan-Teck Lim, et al.
Journal of Geriatric Oncology|March 18, 2015
Do elderly patients benefit from enrollment into Phase I Trials?Wai Meng Tai, Cindy Lim, Aziah Ahmad, et al.
Journal of Cellular and Molecular Medicine|May 10, 2008
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinomaHung Huynh, K H Pierce Chow, Khee Chee Soo, et al.
Journal of Cellular and Molecular Medicine|February 18, 2009
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHung Huynh, Van Chanh Ngo, Heng Nung Koong, et al.
Plos One|November 6, 2014
Potentially functional SNPs (pfSNPs) as novel genomic predictors of 5-FU response in metastatic colorectal cancer patientsJingbo Wang, Xu Wang, Mingjue Zhao, et al.
Asia-Pacific Journal of Clinical Oncology|September 3, 2020
Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian CenterKennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Oncology|March 8, 2011
Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinomaSoo-Fan Ang, Sze-Huey Tan, Han-Chong Toh, et al.
Cancer Chemotherapy and Pharmacology|June 1, 2012
Phase I pharmacokinetic study of chronomodulated dose-intensified combination of capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancerMohamad Farid, Balram Chowbay, Xiangai Chen, et al.
Asia-Pacific Journal of Clinical Oncology|April 18, 2020
Recommendations to improve the clinical adoption of NGS-based cancer diagnostics in SingaporeDavid Shao-Peng Tan, Daniel Shao-Weng Tan, Iain Bee Huat Tan, et al.
Asia-Pacific Journal of Clinical Oncology|December 1, 2010
Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathyWen-Yee Chay, Sze-Huey Tan, Yew-Long Lo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysisChee-Kian Tham, Su-Pin Choo, Wan-Teck Lim, et al.
Journal of Geriatric Oncology|March 18, 2015
Do elderly patients benefit from enrollment into Phase I Trials?Wai Meng Tai, Cindy Lim, Aziah Ahmad, et al.
Journal of Cellular and Molecular Medicine|May 10, 2008
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinomaHung Huynh, K H Pierce Chow, Khee Chee Soo, et al.
Journal of Cellular and Molecular Medicine|February 18, 2009
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHung Huynh, Van Chanh Ngo, Heng Nung Koong, et al.
Plos One|November 6, 2014
Potentially functional SNPs (pfSNPs) as novel genomic predictors of 5-FU response in metastatic colorectal cancer patientsJingbo Wang, Xu Wang, Mingjue Zhao, et al.
Asia-Pacific Journal of Clinical Oncology|September 3, 2020
Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian CenterKennedy Yao Yi Ng, Lawrence Wen Jun Wong, Andrea Jing Shi Ang, et al.
Pageof 11